Survey assessing the Member States’ rules on health data in the light of GDPR The European Commission has initiated a study that aims to examine in which manners the processing […]
Read MoreMay – June 2020 Edition has been released today! This released edition has a flash news style (read 5-7 min) with info on nomination call for a Committee, leadership changes, […]
Read MoreMay – June 2020 Edition has been released today! This released edition has a flash news style (read 5-7 min) with info on nomination call for a Committee, leadership changes, […]
Read MoreJune 3, 2020 Dr.
Read MoreJune 3, 2020 Dr. Katherine Beaverson has been elected as new Chair of the IRDiRC Company Constituent Committee (CCC), she is the Patient Advocacy Director for the Rare Disease Research Unit at Pfizer. The […]
Read MoreJune 3, 2020 IRDiRC welcomes Illumina Inc. as new member to its Company Constituent Committee, which
Read MoreJune 3, 2020 IRDiRC welcomes Illumina Inc. as new member to its Company Constituent Committee, which brings together representatives from the for-profit pharmaceutical and biotech members of IRDiRC. Illumina is […]
Read MoreJune 2, 2020 The U.S. Food and Drug Administration (FDA) announced a Request for Information and Comment on Rare Disease Clinical Trial Networks. In particular, the FDA is requesting public input […]
Read MoreJune 2, 2020 The U.S. Food and Drug Administration (FDA) announced a Request for Information and Comment on Rare Disease Clinical Trial Networks. In particular, the FDA is requesting public input […]
Read MoreIRDiRC has been actively involved in the ECRD online conference that will take place this week: May 14 – 15, 2020.In particular, IRDiRC members joined several events planned during this […]
Read More